Ahaviah Glaser Named GPhA VP for Policy and Strategic Alliances

Published Online: Friday, December 9, 2011
Follow Pharmacy_Times:
Ahaviah Glaser has joined the Generic Pharmaceutical Association (GPhA) as vice president for Policy & Strategic Alliances, effective immediately. Glaser joins the Association from AARP’s Government Affairs team and the Law & Government Program of American University’s Washington College of Law.

“Through GPhA and the newly-created Affordable Medicines Research Institute, Havi will help educate both the public at large and policy makers around the world about the safety and efficacy of generic medicines as well as the extraordinary health care savings that generics provide,” said GPhA President and CEO Ralph G. Neas, in a statement.

“In a time when budget challenges and health care costs are colliding as never before, not only for governments but for families, Havi’s job will be to help shepherd research, education and outreach efforts to ensure that all Americans fully understand that generic pharmaceuticals reduce health care costs while maintaining the high-quality standard of care that they rightly expect,” Neas added.

Glaser’s hiring represents a significant step in GPhA’s plan to use cutting-edge research and strategic alliances to make sure that the importance of generic medicines is widely understood, especially in emerging opportunities such as the generic biologics market.

Ms. Glaser has a wide-ranging background, which will help ensure that GPhA’s policy concerns will be approached from multiple angles. She holds a law degree from the University of Michigan and earned a Bachelor of Science degree from the University of California at Berkeley. As an attorney, she has litigated key cases in the private sector, lobbied Congress, drafted legislation, worked with regulatory agencies and led diverse coalitions, all in an effort to expand access to safe, affordable prescription medication.

She is also an experienced educator, most recently serving as an adjunct professor in the Washington College of Law’s Health Law and Policy Institute since 2006. Immediately before coming to GPhA, Ms. Glaser served as AARP’s lead lobbyist on Medicare, Medicaid and pharmaceutical policy.
Related Articles
Erin Albert, MBA, PharmD, JD, returns to the show­ with some advice for pharmacy's future leaders and recent graduates of pharmacy.
The Kentucky Board of Pharmacy has passed an emergency regulation permitting the state’s pharmacists to dispense the opioid overdose antidote naloxone without a prescription.
Jennifer Goldman, PharmD, CDE, BC-ADM, FCCP, professor of pharmacy practice at MCPHS University, discusses the role pharmacists can play when helping clinicians overcome barriers to initiating insulin use.
The demand for pharmacists is rising across the nation, according to Aggregate Demand Index figures.
$vacMongoViewPlus$
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$